MGI Pharma MOGN New patents, anti cancer Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Cathcart who wrote (689)	2/17/1998 10:12:00 PM
From: the eagle	Read Replies (1) of 1826

david, did you see the post on yahoo about insider buying that was attributable to some newspaper article. has anyone else seen this article and, if so, maybe it could be posted on this thread. this company is on the verge of being profitable, has a potentially blockbuster drug with hopefully a partner from europe to pay the fda expense. in bioteck this seems like a no brainer up to about $10. plus, they have 15mil in the bank. i have seen bios in the past trade to $50 and they have not even completed phase1. someone argue with me and tell me why my argument is flawed. that is what this thread should be about----so all of us can make intelligent investment decsions.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next